69 related articles for article (PubMed ID: 7689935)
1. Modulation of p145c-kit function in cells of patients with acute myeloblastic leukemia.
Bühring HJ; Herbst R; Kostka G; Bossenmaier B; Bartke I; Kropshofer H; Kalbacher H; Busch FW; Müller CA; Schlessinger J
Cancer Res; 1993 Sep; 53(18):4424-31. PubMed ID: 7689935
[TBL] [Abstract][Full Text] [Related]
2. Epitope mapping and functional studies with three monoclonal antibodies to the c-kit receptor tyrosine kinase, YB5.B8, 17F11, and SR-1.
Ashman LK; Bühring HJ; Aylett GW; Broudy VC; Müller C
J Cell Physiol; 1994 Mar; 158(3):545-54. PubMed ID: 7510297
[TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor-beta 1 interferes with the proliferation-inducing activity of stem cell factor in myelogenous leukemia blasts through functional down-regulation of the c-kit proto-oncogene product.
de Vos S; Brach MA; Asano Y; Ludwig WD; Bettelheim P; Gruss HJ; Herrmann F
Cancer Res; 1993 Aug; 53(15):3638-42. PubMed ID: 7687925
[TBL] [Abstract][Full Text] [Related]
4. Changes in phenotype and proliferative potential of human acute myeloblastic leukemia cells in culture with stem cell factor.
Ikeda H; Kanakura Y; Furitsu T; Kitayama H; Sugahara H; Nishiura T; Karasuno T; Tomiyama Y; Yamatodani A; Kanayama Y
Exp Hematol; 1993 Dec; 21(13):1686-94. PubMed ID: 7694869
[TBL] [Abstract][Full Text] [Related]
5. The product of the proto-oncogene c-kit (P145c-kit) is a human bone marrow surface antigen of hemopoietic precursor cells which is expressed on a subset of acute non-lymphoblastic leukemic cells.
Bühring HJ; Ullrich A; Schaudt K; Müller CA; Busch FW
Leukemia; 1991 Oct; 5(10):854-60. PubMed ID: 1720490
[TBL] [Abstract][Full Text] [Related]
6. Effects of mast cell growth factor on Ara-C mediated acute myeloid leukemia cell killing.
Tafuri A; De Felice L; Mascolo MG; Valentini T; Petrucci MT; Petti MC
Stem Cells; 1993 Jul; 11 Suppl 2():88-92. PubMed ID: 7691332
[TBL] [Abstract][Full Text] [Related]
7. Effects of signal transduction inhibitor 571 in acute myelogenous leukemia cells.
Scappini B; Onida F; Kantarjian HM; Dong L; Verstovsek S; Keating MJ; Beran M
Clin Cancer Res; 2001 Dec; 7(12):3884-93. PubMed ID: 11751479
[TBL] [Abstract][Full Text] [Related]
8. Relationship between c-Kit expression and proliferation in acute myeloblastic leukemia cell lines.
Tohda S; Yang GS; Ashman LK; McCulloch EA; Minden MD
J Cell Physiol; 1993 Feb; 154(2):410-8. PubMed ID: 7678840
[TBL] [Abstract][Full Text] [Related]
9. Implication of tyrosine kinase receptor and steel factor in cell density-dependent growth in cervical cancers and leukemias.
Caceres-Cortes JR; Alvarado-Moreno JA; Waga K; Rangel-Corona R; Monroy-Garcia A; Rocha-Zavaleta L; Urdiales-Ramos J; Weiss-Steider B; Haman A; Hugo P; Brousseau R; Hoang T
Cancer Res; 2001 Aug; 61(16):6281-9. PubMed ID: 11507083
[TBL] [Abstract][Full Text] [Related]
10. In vivo differentiation of mast cells from acute myeloid leukemia blasts carrying a novel activating ligand-independent C-kit mutation.
Beghini A; Cairoli R; Morra E; Larizza L
Blood Cells Mol Dis; 1998 Jun; 24(2):262-70. PubMed ID: 9714703
[TBL] [Abstract][Full Text] [Related]
11. [The Steel factor].
Cáceres-Cortés JR
Rev Invest Clin; 1997; 49(6):507-14. PubMed ID: 9528312
[TBL] [Abstract][Full Text] [Related]
12. c-Kit receptor (CD117) expression on myeloblasts and white blood cell counts in acute myeloid leukemia.
Woźniak J; Kopeć-Szlezak J
Cytometry B Clin Cytom; 2004 Mar; 58(1):9-16. PubMed ID: 14994370
[TBL] [Abstract][Full Text] [Related]
13. Human stem cell factor-antibody [anti-SCF] enhances chemotherapy cytotoxicity in human CD34+ resistant myeloid leukaemia cells.
Lu C; Hassan HT
Leuk Res; 2006 Mar; 30(3):296-302. PubMed ID: 16112192
[TBL] [Abstract][Full Text] [Related]
14. IL-3-dependent murine mast cells undergo apoptosis on removal of IL-3. Prevention of apoptosis by c-kit ligand.
Mekori YA; Oh CK; Metcalfe DD
J Immunol; 1993 Oct; 151(7):3775-84. PubMed ID: 7690814
[TBL] [Abstract][Full Text] [Related]
15. Thrombopoietin stimulates murine lineage negative, Sca-1+, C-Kit+, CD34- cells: comparative study with stem cell factor or interleukin-3.
Shimomura T; Yonemura Y; Miyazoe T; Miyake H; Kato T; Miyazaki H; Mitsuya H; Kawakita M
Int J Hematol; 2000 Jan; 71(1):33-9. PubMed ID: 10729991
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of Kit expression by IL-4 and IL-10 in murine mast cells: role of STAT6 and phosphatidylinositol 3'-kinase.
Mirmonsef P; Shelburne CP; Fitzhugh Yeatman C; Chong HJ; Ryan JJ
J Immunol; 1999 Sep; 163(5):2530-9. PubMed ID: 10452990
[TBL] [Abstract][Full Text] [Related]
17. In vitro induction of inhibitory macrophage differentiation by granulocyte-macrophage colony-stimulating factor, stem cell factor and interferon-gamma from lineage phenotypes-negative c-kit-positive murine hematopoietic progenitor cells.
Ferret-Bernard S; Saï P; Bach JM
Immunol Lett; 2004 Feb; 91(2-3):221-7. PubMed ID: 15019293
[TBL] [Abstract][Full Text] [Related]
18. Induction of the murine "W phenotype" in long-term cultures of human cord blood cells by c-kit antisense oligomers.
Migliaccio AR; Migliaccio G; Mancini G; Ratajczak M; Gewirtz AM; Adamson JW
J Cell Physiol; 1993 Oct; 157(1):158-63. PubMed ID: 7691834
[TBL] [Abstract][Full Text] [Related]
19. Structure-function analyses of the kit receptor for the steel factor.
Blechman JM; Lev S; Givol D; Yarden Y
Stem Cells; 1993 Jul; 11 Suppl 2():12-21. PubMed ID: 7691317
[TBL] [Abstract][Full Text] [Related]
20. The in vitro and in vivo effects of stem cell factor on human hematopoiesis.
Hoffman R; Tong J; Brandt J; Traycoff C; Bruno E; McGuire BW; Gordon MS; McNiece I; Srour EF
Stem Cells; 1993 Jul; 11 Suppl 2():76-82. PubMed ID: 7691331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
